SYKE yields 3.70% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, SYKE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYKE + JNJ for your $10,000?
Sykes Enterprises, Incorporated, together with its subsidiaries, provides multichannel demand generation and customer engagement solutions and services. The company's customer care services include handling billing inquiries and claims, activating customer accounts, resolving complaints, cross-selling/up-selling, and prequalifying and warranty management, as well as offers health information and dispatching roadside assistance. Its technical support services comprise support around complex networks, hardware and software, communications equipment, Internet access technology, and Internet portal usage. The company also provides customer acquisition services, which focuses around digital marketing, multichannel demand generation, and inbound up-selling and sales conversion, as well as outbound selling of its clients' products and services. In addition, it offers consulting, implementation, hosting, and managed services that help clients in back-office workflow; fulfillment services, such as order processing, inventory control, product delivery, and product returns handling; and enterprise support services comprising technical staffing services and outsourced corporate help desk solutions. The company provides its services through phone, email, social media, text messaging, chat, and digital self-service support. It serves corporations, medium-sized businesses, and public institutions in the financial services, communications, technology, transportation and leisure, healthcare, and other industries. The company operates in the United States, Canada, Latin America, Australia, the Asia Pacific Rim, Europe, the Middle East, and Africa. Sykes Enterprises, Incorporated was founded in 1977 and is headquartered in Tampa, Florida.
Full SYKE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.